NCT03387085 2024-08-09QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.ImmunityBio, Inc.Phase 1/2 Terminated9 enrolled 18 charts
NCT01920061 2022-09-13A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)PfizerPhase 1 Completed110 enrolled 80 charts